---
ACN:
- - Action Taken with Study Treatment
  - ACN
  - 'false'
  - Terminology specifying changes to the study treatment as a result of an adverse
    event.
  - C66767
  - C17998
  - UNKNOWN
  - Unknown
  - U; Unknown
  - U; Unknown
  - ''
  - ''
  - Unknown
  - '6'
  - '6'
  - 'true'
  - 'true'
  - 'true'
  - ''
- - Action Taken with Study Treatment
  - ACN
  - 'false'
  - Terminology specifying changes to the study treatment as a result of an adverse
    event.
  - C66767
  - C48660
  - NOT APPLICABLE
  - Not Applicable
  - NA; Not Applicable
  - NA; Not Applicable
  - ''
  - ''
  - Not Applicable
  - '7'
  - '7'
  - 'true'
  - 'true'
  - 'true'
  - ''
- - Action Taken with Study Treatment
  - ACN
  - 'false'
  - Terminology specifying changes to the study treatment as a result of an adverse
    event.
  - C66767
  - C49501
  - DRUG INTERRUPTED
  - Drug Interrupted
  - ''
  - ''
  - ''
  - ''
  - Drug Interrupted
  - '3'
  - '3'
  - 'true'
  - 'true'
  - 'true'
  - ''
- - Action Taken with Study Treatment
  - ACN
  - 'false'
  - Terminology specifying changes to the study treatment as a result of an adverse
    event.
  - C66767
  - C49502
  - DRUG WITHDRAWN
  - Drug Withdrawn
  - ''
  - ''
  - ''
  - ''
  - Drug Withdrawn
  - '4'
  - '4'
  - 'true'
  - 'true'
  - 'true'
  - ''
- - Action Taken with Study Treatment
  - ACN
  - 'false'
  - Terminology specifying changes to the study treatment as a result of an adverse
    event.
  - C66767
  - C49503
  - DOSE INCREASED
  - Dose Increased
  - ''
  - ''
  - ''
  - ''
  - Dose Increased
  - '5'
  - '5'
  - 'true'
  - 'true'
  - 'true'
  - ''
- - Action Taken with Study Treatment
  - ACN
  - 'false'
  - Terminology specifying changes to the study treatment as a result of an adverse
    event.
  - C66767
  - C49504
  - DOSE NOT CHANGED
  - Dose Not Changed
  - ''
  - ''
  - ''
  - ''
  - Dose Not Changed
  - '1'
  - '1'
  - 'true'
  - 'true'
  - 'true'
  - ''
- - Action Taken with Study Treatment
  - ACN
  - 'false'
  - Terminology specifying changes to the study treatment as a result of an adverse
    event.
  - C66767
  - C49505
  - DOSE REDUCED
  - Dose Reduced
  - ''
  - ''
  - ''
  - ''
  - Dose Reduced
  - '2'
  - '2'
  - 'true'
  - 'true'
  - 'true'
  - ''
- - Action Taken with Study Treatment
  - ACN
  - 'false'
  - Terminology specifying changes to the study treatment as a result of an adverse
    event.
  - C66767
  - C78728
  - MULTIPLE
  - Many
  - Many; Several
  - Many; Several
  - ''
  - ''
  - ''
  - ''
  - '8'
  - 'false'
  - 'true'
  - 'true'
  - ''
AERELA:
- - Relationship to Study Treatment
  - AERELA
  - 'false'
  - Used to determine the relationship of Adverse Event to study treatment.
  - SN000012
  - C78728
  - MULTIPLE
  - Many
  - Many; Several
  - Many; Several
  - ''
  - ''
  - ''
  - ''
  - '5'
  - 'false'
  - 'true'
  - 'true'
  - ''
- - Relationship to Study Treatment
  - AERELA
  - 'false'
  - Used to determine the relationship of Adverse Event to study treatment.
  - SN000012
  - S000090
  - NOT RELATED
  - Not Related
  - ''
  - ''
  - ''
  - ''
  - Not Related
  - '1'
  - '1'
  - 'true'
  - 'true'
  - 'true'
  - ''
- - Relationship to Study Treatment
  - AERELA
  - 'false'
  - Used to determine the relationship of Adverse Event to study treatment.
  - SN000012
  - S000092
  - POSSIBLY RELATED
  - Possibly Related
  - ''
  - ''
  - ''
  - ''
  - Possibly Related
  - '3'
  - '3'
  - 'true'
  - 'true'
  - 'true'
  - ''
- - Relationship to Study Treatment
  - AERELA
  - 'false'
  - Used to determine the relationship of Adverse Event to study treatment.
  - SN000012
  - S000093
  - RELATED
  - Related
  - ''
  - ''
  - ''
  - ''
  - Related
  - '4'
  - '4'
  - 'true'
  - 'true'
  - 'true'
  - ''
- - Relationship to Study Treatment
  - AERELA
  - 'false'
  - Used to determine the relationship of Adverse Event to study treatment.
  - SN000012
  - S000094
  - UNLIKELY RELATED
  - Unlikely Related
  - ''
  - ''
  - ''
  - ''
  - Unlikely Related
  - '2'
  - '2'
  - 'true'
  - 'true'
  - 'true'
  - ''
AERELDEV_01:
- - Relationship to Device Subset 01
  - AERELDEV_01
  - 'false'
  - Used to determine the relationship of Adverse Event to device.
  - SN001877
  - S000090
  - NOT RELATED
  - Not Related
  - ''
  - ''
  - A characteristic used to qualify the adverse event as clearly not related to the
    study treatment.
  - ''
  - Not Related
  - '2'
  - '1'
  - 'true'
  - 'true'
  - 'false'
  - ''
- - Relationship to Device Subset 01
  - AERELDEV_01
  - 'false'
  - Used to determine the relationship of Adverse Event to device.
  - SN001877
  - S000093
  - RELATED
  - Related
  - ''
  - ''
  - A characteristic used to qualify the adverse event as related to the study treatment.
  - ''
  - Related
  - '1'
  - '2'
  - 'true'
  - 'true'
  - 'false'
  - ''
AGEGRPE:
- - Age Group (EudraCT)
  - AGEGRPE
  - 'false'
  - Age category used for EudraCT demographics table.
  - SN000018
  - S000109
  - ADOLESCENTS (12-17 YEARS)
  - ADOLESCENTS (12-17 YEARS)
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '6'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Age Group (EudraCT)
  - AGEGRPE
  - 'false'
  - Age category used for EudraCT demographics table.
  - SN000018
  - S000110
  - CHILDREN (2-11 YEARS)
  - CHILDREN (2-11 YEARS)
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '5'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Age Group (EudraCT)
  - AGEGRPE
  - 'false'
  - Age category used for EudraCT demographics table.
  - SN000018
  - S000111
  - FROM 18 - 64 YEARS
  - FROM 18 - 64 YEARS
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '7'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Age Group (EudraCT)
  - AGEGRPE
  - 'false'
  - Age category used for EudraCT demographics table.
  - SN000018
  - S000112
  - FROM 65 - 84 YEARS
  - FROM 65 - 84 YEARS
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '8'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Age Group (EudraCT)
  - AGEGRPE
  - 'false'
  - Age category used for EudraCT demographics table.
  - SN000018
  - S000113
  - IN UTERO
  - IN UTERO
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '1'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Age Group (EudraCT)
  - AGEGRPE
  - 'false'
  - Age category used for EudraCT demographics table.
  - SN000018
  - S000114
  - INFANTS AND TODDLERS (28 DAYS - 23 MONTHS)
  - INFANTS AND TODDLERS (28 DAYS - 23 MONTHS)
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '4'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Age Group (EudraCT)
  - AGEGRPE
  - 'false'
  - Age category used for EudraCT demographics table.
  - SN000018
  - S000115
  - NEWBORNS (0-27 DAYS)
  - NEWBORNS (0-27 DAYS)
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '3'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Age Group (EudraCT)
  - AGEGRPE
  - 'false'
  - Age category used for EudraCT demographics table.
  - SN000018
  - S000117
  - PRETERM NEWBORN - GESTATIONAL AGEP < 37 WKS
  - PRETERM NEWBORN - GESTATIONAL AGEP < 37 WKS
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '2'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Age Group (EudraCT)
  - AGEGRPE
  - 'false'
  - Age category used for EudraCT demographics table.
  - SN000018
  - S009907
  - 85 YEARS AND OVER
  - 85 YEARS AND OVER
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '9'
  - 'false'
  - 'false'
  - 'true'
  - ''
AGEGRPPN:
- - Age Group (Pediatric) Numeric
  - AGEGRPPN
  - 'false'
  - Numeric - Age category used for pediatric study PCSA Criteria.
  - SN000021
  - S000127
  - '2'
  - INFANTS
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '2'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Age Group (Pediatric) Numeric
  - AGEGRPPN
  - 'false'
  - Numeric - Age category used for pediatric study PCSA Criteria.
  - SN000021
  - S000132
  - '3'
  - YOUNGER CHILDREN
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '3'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Age Group (Pediatric) Numeric
  - AGEGRPPN
  - 'false'
  - Numeric - Age category used for pediatric study PCSA Criteria.
  - SN000021
  - S000145
  - '1'
  - NEONATES
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '1'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Age Group (Pediatric) Numeric
  - AGEGRPPN
  - 'false'
  - Numeric - Age category used for pediatric study PCSA Criteria.
  - SN000021
  - S000146
  - '4'
  - OLDER CHILDREN
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '4'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Age Group (Pediatric) Numeric
  - AGEGRPPN
  - 'false'
  - Numeric - Age category used for pediatric study PCSA Criteria.
  - SN000021
  - S000147
  - '5'
  - ADOLESCENTS
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '5'
  - 'false'
  - 'false'
  - 'true'
  - ''
NORMEDN:
- - Normalized Identifier Numeric
  - NORMEDN
  - 'false'
  - Numeric - Indicator of norrmalization of PCSA (return to equal or lesser PCSA
    as compared to baseline PCSA).
  - SN000394
  - S003126
  - '0'
  - No worsening as compared to the baseline pcsa status
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '1'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Normalized Identifier Numeric
  - NORMEDN
  - 'false'
  - Numeric - Indicator of norrmalization of PCSA (return to equal or lesser PCSA
    as compared to baseline PCSA).
  - SN000394
  - S003127
  - '3'
  - Never returned to baseline pcsa status
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '4'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Normalized Identifier Numeric
  - NORMEDN
  - 'false'
  - Numeric - Indicator of norrmalization of PCSA (return to equal or lesser PCSA
    as compared to baseline PCSA).
  - SN000394
  - S003128
  - '4'
  - No assessment after elevation
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '5'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Normalized Identifier Numeric
  - NORMEDN
  - 'false'
  - Numeric - Indicator of norrmalization of PCSA (return to equal or lesser PCSA
    as compared to baseline PCSA).
  - SN000394
  - S003129
  - '2'
  - Returned to baseline pcsa status after last imp dose
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '3'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Normalized Identifier Numeric
  - NORMEDN
  - 'false'
  - Numeric - Indicator of norrmalization of PCSA (return to equal or lesser PCSA
    as compared to baseline PCSA).
  - SN000394
  - S003130
  - '1'
  - Returned to baseline pcsa status before last imp dose
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '2'
  - 'false'
  - 'false'
  - 'true'
  - ''
SEVRS:
- - Severity Response
  - SEVRS
  - 'true'
  - Terminology relevant to a severity scale that describes the degree or intensity
    of a notable event or finding.
  - SC165643
  - S011102
  - MAJOR
  - Major
  - '3'
  - '3'
  - ''
  - ''
  - Major
  - '4'
  - '4'
  - 'true'
  - 'true'
  - 'true'
  - ''
- - Severity Response
  - SEVRS
  - 'true'
  - Terminology relevant to a severity scale that describes the degree or intensity
    of a notable event or finding.
  - SC165643
  - S011103
  - MINOR
  - Minor
  - 1; Low
  - 1; Low
  - ''
  - ''
  - Minor
  - '2'
  - '2'
  - 'true'
  - 'true'
  - 'true'
  - ''
- - Severity Response
  - SEVRS
  - 'true'
  - Terminology relevant to a severity scale that describes the degree or intensity
    of a notable event or finding.
  - SC165643
  - SC17998
  - U
  - Unknown
  - U; UNK; Unknown
  - U; UNK; Unknown
  - ''
  - ''
  - Unknown
  - '6'
  - '6'
  - 'true'
  - 'true'
  - 'true'
  - ''
- - Severity Response
  - SEVRS
  - 'true'
  - Terminology relevant to a severity scale that describes the degree or intensity
    of a notable event or finding.
  - SC165643
  - SC61376
  - MODERATE
  - Moderate
  - ''
  - ''
  - ''
  - ''
  - Moderate
  - '3'
  - '3'
  - 'true'
  - 'true'
  - 'true'
  - ''
- - Severity Response
  - SEVRS
  - 'true'
  - Terminology relevant to a severity scale that describes the degree or intensity
    of a notable event or finding.
  - SC165643
  - SC70666
  - MILD
  - Mild
  - ''
  - ''
  - ''
  - ''
  - Mild
  - '1'
  - '1'
  - 'true'
  - 'true'
  - 'true'
  - ''
- - Severity Response
  - SEVRS
  - 'true'
  - Terminology relevant to a severity scale that describes the degree or intensity
    of a notable event or finding.
  - SC165643
  - SC70667
  - SEVERE
  - Severe
  - ''
  - ''
  - ''
  - ''
  - Severe
  - '5'
  - '5'
  - 'true'
  - 'true'
  - 'true'
  - ''
SHIFT2N:
- - Shift of Normality from Baseline Numeric
  - SHIFT2N
  - 'true'
  - Numeric - A description of the shift of normality from baseline.
  - SN000550
  - S000229
  - '1'
  - Abnormal to Normal
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '1'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Shift of Normality from Baseline Numeric
  - SHIFT2N
  - 'true'
  - Numeric - A description of the shift of normality from baseline.
  - SN000550
  - S003276
  - '2'
  - Normal/Missing to Abnormal
  - ''
  - ''
  - ''
  - ''
  - ''
  - ''
  - '2'
  - 'false'
  - 'false'
  - 'true'
  - ''
TOXGR_01:
- - Common Terminology Criteria for Adverse Events Subset 01
  - TOXGR_01
  - 'false'
  - The standard terminology developed to report adverse events occurring in cancer
    clinical trials. Common terminology criteria for adverse events (CTCAE) are used
    to study adverse event summaries and Investigational New Drug reports to the Food.
  - SN001030
  - S011595
  - '1'
  - Mild Adverse Event
  - Mild Adverse Event
  - Mild Adverse Event
  - "(Synonym 1 NCI) An adverse event that is asymptomatic; or involves mild or minor
    symptoms; or is of marginal clinical relevance; or consists of clinical or diagnostic
    observations alone; or for which intervention is not indicated; or for which only
    non-prescription intervention is indicated."
  - ''
  - Grade 1
  - '1'
  - '1'
  - 'true'
  - 'false'
  - 'true'
  - ''
- - Common Terminology Criteria for Adverse Events Subset 01
  - TOXGR_01
  - 'false'
  - The standard terminology developed to report adverse events occurring in cancer
    clinical trials. Common terminology criteria for adverse events (CTCAE) are used
    to study adverse event summaries and Investigational New Drug reports to the Food.
  - SN001030
  - S011596
  - '2'
  - Moderate Adverse Event
  - Moderate Adverse Event
  - Moderate Adverse Event
  - "(Synonym 1 NCI) An adverse event for which only minimal, local, or noninvasive
    intervention (e.g. packing, cautery) is indicated; or that limits instrumental
    activities of daily living (ADLs, e.g., shopping, laundry, transportation, or
    ability to conduct finances)."
  - ''
  - Grade 2
  - '2'
  - '2'
  - 'true'
  - 'false'
  - 'true'
  - ''
- - Common Terminology Criteria for Adverse Events Subset 01
  - TOXGR_01
  - 'false'
  - The standard terminology developed to report adverse events occurring in cancer
    clinical trials. Common terminology criteria for adverse events (CTCAE) are used
    to study adverse event summaries and Investigational New Drug reports to the Food.
  - SN001030
  - S011597
  - '3'
  - Severe Adverse Event
  - Severe Adverse Event
  - Severe Adverse Event
  - "(Synonym 1 NCI) An adverse event that is medically significant but not life-threatening;
    or for which inpatient care or prolongation of hospitalization are indicated;
    or that is an important medical event that does not result in hospitalization,
    but may jeopardize the patient or may require intervention either to prevent hospitalization,
    to prevent the AE from becoming life-threatening or causing death; or that is
    disabling; or that results in persistent or significant disability, incapacity,
    or limitation of self care activities of daily living (ADLs, e.g., getting in
    and out of bed, dressing, eating, getting around inside, bathing, or using the
    toilet)."
  - ''
  - Grade 3
  - '3'
  - '3'
  - 'true'
  - 'false'
  - 'true'
  - ''
- - Common Terminology Criteria for Adverse Events Subset 01
  - TOXGR_01
  - 'false'
  - The standard terminology developed to report adverse events occurring in cancer
    clinical trials. Common terminology criteria for adverse events (CTCAE) are used
    to study adverse event summaries and Investigational New Drug reports to the Food.
  - SN001030
  - S011598
  - '4'
  - Life Threatening Adverse Event
  - Life Threatening Adverse Event
  - Life Threatening Adverse Event
  - "(Synonym 1 NCI) An adverse event that has life-threatening consequences; for
    which urgent intervention is indicated; that puts the patient at risk of death
    at the time of the event if immediate intervention is not undertaken; or that
    causes blindness or deafness."
  - ''
  - Grade 4
  - '4'
  - '4'
  - 'true'
  - 'false'
  - 'true'
  - ''
- - Common Terminology Criteria for Adverse Events Subset 01
  - TOXGR_01
  - 'false'
  - The standard terminology developed to report adverse events occurring in cancer
    clinical trials. Common terminology criteria for adverse events (CTCAE) are used
    to study adverse event summaries and Investigational New Drug reports to the Food.
  - SN001030
  - S011599
  - '5'
  - Death Related to Adverse Event
  - Death Related to Adverse Event
  - Death Related to Adverse Event
  - "(Synonym 1 NCI) The termination of life as a result of an adverse event. (NCI)"
  - ''
  - Grade 5
  - '5'
  - '5'
  - 'true'
  - 'false'
  - 'true'
  - ''
TOXGRN:
- - Common Terminology Criteria for Adverse Events Numeric
  - TOXGRN
  - 'false'
  - Numeric -Standard terminology developed to report adverse events occurring in
    cancer clinical trials. Common terminology criteria for adverse events (CTCAE)
    are used to study adverse event summaries and Investigational New Drug reports
    to the Food and Drug Administration. The CTCAE contain a grading scale for each
    adverse event term representing the severity of the event.
  - SN001072
  - S017114
  - "-1"
  - No Abnormality
  - ''
  - ''
  - ''
  - ''
  - ''
  - '1'
  - '1'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Common Terminology Criteria for Adverse Events Numeric
  - TOXGRN
  - 'false'
  - Numeric -Standard terminology developed to report adverse events occurring in
    cancer clinical trials. Common terminology criteria for adverse events (CTCAE)
    are used to study adverse event summaries and Investigational New Drug reports
    to the Food and Drug Administration. The CTCAE contain a grading scale for each
    adverse event term representing the severity of the event.
  - SN001072
  - S017640
  - '1'
  - Mild Adverse Event
  - ''
  - ''
  - ''
  - ''
  - ''
  - '2'
  - '2'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Common Terminology Criteria for Adverse Events Numeric
  - TOXGRN
  - 'false'
  - Numeric -Standard terminology developed to report adverse events occurring in
    cancer clinical trials. Common terminology criteria for adverse events (CTCAE)
    are used to study adverse event summaries and Investigational New Drug reports
    to the Food and Drug Administration. The CTCAE contain a grading scale for each
    adverse event term representing the severity of the event.
  - SN001072
  - S017641
  - '2'
  - Moderate Adverse Event
  - ''
  - ''
  - ''
  - ''
  - ''
  - '3'
  - '3'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Common Terminology Criteria for Adverse Events Numeric
  - TOXGRN
  - 'false'
  - Numeric -Standard terminology developed to report adverse events occurring in
    cancer clinical trials. Common terminology criteria for adverse events (CTCAE)
    are used to study adverse event summaries and Investigational New Drug reports
    to the Food and Drug Administration. The CTCAE contain a grading scale for each
    adverse event term representing the severity of the event.
  - SN001072
  - S017642
  - '3'
  - Severe Adverse Event
  - ''
  - ''
  - ''
  - ''
  - ''
  - '4'
  - '4'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Common Terminology Criteria for Adverse Events Numeric
  - TOXGRN
  - 'false'
  - Numeric -Standard terminology developed to report adverse events occurring in
    cancer clinical trials. Common terminology criteria for adverse events (CTCAE)
    are used to study adverse event summaries and Investigational New Drug reports
    to the Food and Drug Administration. The CTCAE contain a grading scale for each
    adverse event term representing the severity of the event.
  - SN001072
  - S017643
  - '4'
  - Life Threatening Adverse Event
  - ''
  - ''
  - ''
  - ''
  - ''
  - '5'
  - '5'
  - 'false'
  - 'false'
  - 'true'
  - ''
- - Common Terminology Criteria for Adverse Events Numeric
  - TOXGRN
  - 'false'
  - Numeric -Standard terminology developed to report adverse events occurring in
    cancer clinical trials. Common terminology criteria for adverse events (CTCAE)
    are used to study adverse event summaries and Investigational New Drug reports
    to the Food and Drug Administration. The CTCAE contain a grading scale for each
    adverse event term representing the severity of the event.
  - SN001072
  - S017644
  - '5'
  - Death Related to Adverse Event
  - ''
  - ''
  - ''
  - ''
  - ''
  - '6'
  - '6'
  - 'false'
  - 'false'
  - 'true'
  - ''
